BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11916515)

  • 1. Identification of two atypical PML-RAR(alpha) transcripts in two patients with acute promyelocytic leukemia.
    Barragán E; Bolufer P; Martín G; Cervera J; Moreno I; Capote FJ; Rosique P; Sanz MA
    Leuk Res; 2002 May; 26(5):439-42. PubMed ID: 11916515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
    Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.
    Gallagher RE; Li YP; Rao S; Paietta E; Andersen J; Etkind P; Bennett JM; Tallman MS; Wiernik PH
    Blood; 1995 Aug; 86(4):1540-7. PubMed ID: 7632962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction.
    Chen SJ; Chen Z; Chen A; Tong JH; Dong S; Wang ZY; Waxman S; Zelent A
    Oncogene; 1992 Jun; 7(6):1223-32. PubMed ID: 1375719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of PML-retinoic acid receptor-alpha fusion transcripts in acute promyelocytic leukemia with trisomy 8 but without t(15;17).
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Am J Hematol; 1994 Mar; 45(3):212-6. PubMed ID: 8296791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal deletion of the long arm of chromosome 9 in acute promyelocytic leukemia with a cryptic PML/RAR alpha rearrangement.
    Yamamoto K; Hamaguchi H; Kobayashi M; Tsurukubo Y; Nagata K
    Cancer Genet Cytogenet; 1999 Sep; 113(2):120-5. PubMed ID: 10484977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring of minimal residual disease with the combined detection of PML/RAR alpha and RAR alpha/PML rearrangements in acute promyelocytic leukemia].
    Bolufer P; Barragán E; Sanz MA; Martín G; Lerma E; Afán de Ribera E
    Med Clin (Barc); 2000 Mar; 114(8):281-5. PubMed ID: 10774514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
    Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
    Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia.
    Kane JR; Head DR; Balazs L; Hulshof MG; Motroni TA; Raimondi SC; Carroll AJ; Behm FG; Krance RA; Shurtleff SA; Downing JR
    Leukemia; 1996 Aug; 10(8):1296-302. PubMed ID: 8709634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.
    Gallagher RE; Willman CL; Slack JL; Andersen JW; Li YP; Viswanatha D; Bloomfield CD; Appelbaum FR; Schiffer CA; Tallman MS; Wiernik PH
    Blood; 1997 Aug; 90(4):1656-63. PubMed ID: 9269786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.
    Gallagher RE; Yeap BY; Bi W; Livak KJ; Beaubier N; Rao S; Bloomfield CD; Appelbaum FR; Tallman MS; Slack JL; Willman CL
    Blood; 2003 Apr; 101(7):2521-8. PubMed ID: 12468436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.
    Miller WH; Kakizuka A; Frankel SR; Warrell RP; DeBlasio A; Levine K; Evans RM; Dmitrovsky E
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2694-8. PubMed ID: 1372989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse transcription polymerase chain reaction for the diagnosis and molecular monitoring of the PML/RAR alpha fusion gene in acute promyelocytic leukemia.
    Viniou NA; Yataganas X; Stamatopoulos K; Xefteri I; Kalmantis T; Papasavas P; Mitsulis C; Rombos J; Meletis J; Bourantas K
    Cancer Genet Cytogenet; 1995 Oct; 84(2):91-4. PubMed ID: 8536228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.
    Perego RA; Marenco P; Bianchi C; Cairoli R; Urbano M; Nosari AM; Muti G; Morra E; Del Monte U
    Leukemia; 1996 Feb; 10(2):207-12. PubMed ID: 8637228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of minimal residual disease by reverse transcriptase polymerase chain reaction for the PML/RAR alpha fusion mRNA: a study in patients with acute promyelocytic leukemia following peripheral stem cell transplantation.
    Takatsuki H; Umemura T; Sadamura S; Yamashita S; Goto T; Abe Y; Yufu Y; Inaba S; Nishimura J; Nawata H
    Leukemia; 1995 May; 9(5):889-92. PubMed ID: 7539517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of RAR alpha-PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long-term remission of acute promyelocytic leukaemia.
    Tobal K; Saunders MJ; Grey MR; Yin JA
    Br J Haematol; 1995 Jul; 90(3):615-8. PubMed ID: 7647002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid practical RT-PCR-based approach for the detection of the PML/RAR alpha fusion transcript in acute promyelocytic leukemia.
    Hussey CE; Lyon E; Millson A; Lay MJ; Wittwer CT; Segal GH
    Am J Clin Pathol; 1999 Aug; 112(2):256-62. PubMed ID: 10439807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.